Pericardiocentesis versus pericardiotomy for malignant pericardial effusion: A retrospective comparison

Current Oncology

Volumn 22, Issue 6, 2015, Pages 412-416

  Labbé, Catherine ^a   Tremblay, L ^a   Lacasse, Y ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Complications; Diagnostic yield; Malignant pericardial effusion; Pericardiocentesis; Pericardiotomy; Recurrence; Survival

Indexed keywords

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; ATRIAL FIBRILLATION; ATRIOVENTRICULAR BLOCK; BACTEREMIA; BRONCHOSPASM; COMPARATIVE STUDY; CYTOLOGY; DEEP VEIN THROMBOSIS; DELIRIUM; DISEASE ASSOCIATION; FEMALE; HEART TAMPONADE; HUMAN; HYPERKALEMIA; LENGTH OF STAY; LUNG EDEMA; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEOPLASM; PERICARDIAL EFFUSION; PERICARDIOCENTESIS; PERICARDIOTOMY; PNEUMOTHORAX; RECURRENT DISEASE; RETROSPECTIVE STUDY; SCLEROTHERAPY; SURVIVAL;

EID: 84951794846     PISSN: None     EISSN: 17187729     Source Type: Journal    
DOI: 10.3747/co.22.2698     Document Type: Article

References (15)

1. Abraham KP, Reddy V, Gattuso P. Neoplasms metastatic to the heart: review of 3314 consecutive autopsies. Am J Cardiovasc Pathol 1990;3:195-8.
2. Thurber DL, Edwards JE, Achor RW. Secondary malignant tumors of the pericardium. Circulation 1962;26:228-41.
3. Refaat MM, Katz WE. Neoplastic pericardial effusion. Clin Cardiol 2011;34:593-8.
4. Cullinane CA, Paz IB, Smith D, Carter N, Grannis FW Jr. Prognostic factors in the surgical management of pericardial effusion in the patient with concurrent malignancy. Chest 2004;125:1328-34.
5. Vaitkus PT, Herrmann HC, LeWinter MM. Treatment of malignant pericardial effusion. JAMA 1994;272:59-64.
6. Maisch B, Seferović PM, Ristić AD, et al. on behalf of the Task Force on the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology. Guidelines on the diagnosis and management of pericardial diseases executive summary. Eur Heart J 2004;25:587-610.
7. Rafique AM, Patel N, Biner S, et al. Frequency of recurrence of pericardial tamponade in patients with extended versus nonextended pericardial catheter drainage. Am J Cardiol 2011;108:1820-5.
8. Celik S, Lestuzzi C, Cervesato E, et al. Systemic chemotherapy in combination with pericardial window has better outcomes in malignant pericardial effusions. J Thorac Cardiovasc Surg 2014;148:2288-93.
9. Tsang TS, Seward JB, Barnes ME, et al. Outcomes of primary and secondary treatment of pericardial effusion in patients with malignancy. Mayo Clin Proc 2000;75:248-53.
10. Allen KB, Faber LP, Warren WH, Shaar CJ. Pericardial effusion: subxiphoid pericardiostomy versus percutaneous catheter drainage. Ann Thorac Surg 1999;67:437-40.
11. Laham RJ, Cohen DJ, Kuntz RE, Baim DS, Lorell BH, Simons M. Pericardial effusion in patients with cancer: outcome with contemporary management strategies. Heart 1996;75:67-71.
12. Patel N, Rafique AM, Eshaghian S, et al. Retrospective comparison of outcomes, diagnostic value, and complications of percutaneous prolonged drainage versus surgical pericardiotomy of pericardial effusion associated with malignancy. Am J Cardiol 2013;112:1235-9.
13. Jama GM, Scarci M, Bowden J, Marciniak SJ. Palliative treatment for symptomatic malignant pericardial effusion. Interact Cardiovasc Thorac Surg 2014;19:1019-26.
14. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999;94:496- 509.
15. Meyers DG, Meyers RE, Prendergast TW. The usefulness of diagnostic tests on pericardial fluid. Chest 1997;111:1213-21.